These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30820877)

  • 21. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.
    Schadendorf D; Lebbé C; Zur Hausen A; Avril MF; Hariharan S; Bharmal M; Becker JC
    Eur J Cancer; 2017 Jan; 71():53-69. PubMed ID: 27984768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Insights and Advances in the Management of Merkel Cell Carcinoma.
    Banks PD; Sandhu S; Gyorki DE; Johnston ML; Rischin D
    J Oncol Pract; 2016 Jul; 12(7):637-46. PubMed ID: 27407160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Merkel Cell Carcinoma: From Pathobiology to Clinical Management.
    Farooq Baba PU; Rasool Z; Younas Khan I; Cockerell CJ; Wang R; Kassir M; Stege H; Grabbe S; Goldust M
    Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
    Paulson KG; Bhatia S
    J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
    Baker M; Cordes L; Brownell I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options.
    Saini AT; Miles BA
    Onco Targets Ther; 2015; 8():2157-67. PubMed ID: 26316785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options.
    Gehrcken L; Sauerer T; Schaft N; Dörrie J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case of Merkel cell carcinoma with ovarian metastasis.
    Keller N; Haemmerle B; Schmid S
    Gynecol Oncol Rep; 2019 May; 28():76-78. PubMed ID: 30963085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study.
    Bhatia S; Nghiem P; Veeranki SP; Vanegas A; Lachance K; Tachiki L; Chiu K; Boller E; Bharmal M
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35981787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New perspectives in Merkel cell carcinoma.
    Del Marmol V; Lebbé C
    Curr Opin Oncol; 2019 Mar; 31(2):72-83. PubMed ID: 30694842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel.
    Cowey CL; Liu FX; Kim R; Boyd M; Fulcher N; Krulewicz S; Kasturi V; Bhanegaonkar A
    Future Oncol; 2021 Jun; 17(18):2339-2350. PubMed ID: 33709776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics and research progress of ocular Merkel cell carcinoma].
    Zhang S; Jiang LB
    Zhonghua Yan Ke Za Zhi; 2024 May; 60(5):467-471. PubMed ID: 38706087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Extremely Rare Case of Metastatic Merkel Carcinoma of the Liver.
    Thomas M; Mandal A
    Cureus; 2021 Nov; 13(11):e19659. PubMed ID: 34956771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Merkel Cell Carcinoma.
    Strong J; Hallaert P; Brownell I
    Hematol Oncol Clin North Am; 2024 Oct; 38(5):1133-1147. PubMed ID: 39060119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma.
    Torchio M; Cattaneo L; Milione M; Prinzi N; Corti F; Ungari M; Anichini A; Mortarini R; Occhini A; Bertino G; Maurichi A; Coppa J; Di Bartolomeo M; de Braud FG; Pusceddu S
    Front Oncol; 2021; 11():628324. PubMed ID: 34221958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Merkel Cell Carcinoma of the Hand: A Case Report and Review of the Literature.
    Westerveld DR; Hall DJ; Richards WT
    Hand (N Y); 2016 Dec; 11(4):NP24-NP29. PubMed ID: 28149222
    [No Abstract]   [Full Text] [Related]  

  • 37. Single administration of avelumab induced a complete response in thyroid transcription factor 1-positive combined Merkel cell carcinoma.
    Kanemaru H; Fukushima S; Mizukami Y; Sawamura S; Nakamura K; Honda N; Makino K; Kajihara I; Aoi J; Makino T; Kawasaki T; Kudou E; Jhono M; Ito T; Arima N; Ihn H
    J Dermatol; 2020 Nov; 47(11):1317-1321. PubMed ID: 32794263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merkel cell carcinoma: Preparing to go the distance.
    Arumugam M; Jamil A; Amiseno RA; Rosli N; Abdul Shukor N
    Malays J Pathol; 2020 Aug; 42(2):277-281. PubMed ID: 32860382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Merkel cell carcinoma: Clinical and anatomopathological features, management and survival in our centre.
    Francés-Monasterio M; García-Minarro Á; Paredes-Pérez AB; García-Duque O
    Cir Cir; 2020; 88(4):448-452. PubMed ID: 32567591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avelumab and other recent advances in Merkel cell carcinoma.
    Bommareddy PK; Kaufman HL
    Future Oncol; 2017 Dec; 13(30):2771-2783. PubMed ID: 28976209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.